We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Continues Nationwide Inspections of Compounding Pharmacies; Hits 3 More with 483s
FDA Continues Nationwide Inspections of Compounding Pharmacies; Hits 3 More with 483s
The FDA is continuing its nationwide effort to single out compounding facilities that don’t conform to GMP regulations, and it blasted pharmacies in Pennsylvania, Massachusetts and Texas with Form 483s for inadequate sterilization practices.